Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial
Jenkin D., Makinson R., Sanders H., Sampson A., Platt A., Tran N., Dinesh T., Mabbett R., Lawrie A., Quaddy J., Poulton I., Berrie E., Cicconi P., Lambe T.